Targeting Molecular Pathways in Intracranial Metastatic Disease

The discovery and clinical application of agents targeting pivotal molecular pathways in malignancies such as lung, breast, renal cell carcinoma, and melanoma have led to impressive improvements in clinical outcomes. Mutations in epidermal growth factor receptor (EGFR), and rearrangements of anaplas...

Descripción completa

Detalles Bibliográficos
Autores principales: Venur, Vyshak Alva, Cohen, Justine V., Brastianos, Priscilla K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409309/
https://www.ncbi.nlm.nih.gov/pubmed/30886831
http://dx.doi.org/10.3389/fonc.2019.00099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409309/
https://www.ncbi.nlm.nih.gov/pubmed/30886831
http://dx.doi.org/10.3389/fonc.2019.00099

Ejemplares similares